Association between γ-glutamyltransferase, adiponectin and arterial stiffness

Journal of Atherosclerosis and Thrombosis

Volumn 19, Issue 1, 2012, Pages 90-97

  Park, Jong Suk ^a   Kang, Sin Ae ^a   Yoo, Jeong Seon ^a   Ahn, Chul Woo ^a   Cha, Bong Soo ^a   Kim, Kyung Rae ^a   Lee, Hyun Chul ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

glutamyltransferase; Adiponectin; Pulse wave velocity

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTERIAL STIFFNESS; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTICENTER STUDY; PULSE WAVE; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ADIPONECTIN; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROGNOSIS; PULSATILE FLOW; REPUBLIC OF KOREA; RISK FACTORS; VASCULAR STIFFNESS;

EID: 84863030841     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.9779     Document Type: Article

References (40)

1. Teschke R, Brand A, Strohmeyer G: Induction of hepatic microsomal gamma-glutamyltransferase activity ollowing chronic alcohol consumption. Biochem Biophys Res Commun, 1977; 75: 718-724
2. Meisinger C, Doring A, Schneider A, Lowel H, KORA Study Group: Serum gamma-glutamyltransferase is as predictor of incident coronary events in apparently healthy men from the general population. Atherosclerosis, 2006; 189: 297-302
3. Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H, Vorarlberg Health Monitoring and Promotion Program Study Group: Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: An epidemiological investigation in a cohort of 162,944 Austrian adults. Circulation, 2005; 112: 2130-2137
4. Pomperlla A, Emdin M, Passino C, Paolicchi A: The significance ofserum γ-glutamyltransferase in cardiovascular disease. Clin Chem Lab Med, 2004; 42: 1085-1091
5. Poikolainen K, Vartiainen E: Determinants of gammaglutamyl transferase: positive interaction with alcohol and body mass index, negative association with coffee. Am J Epidemiol, 1997; 146: 1019-1024
6. Nakanishi N, Suzuki K, Tatara K: Serum gamma-glutamyl transferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care, 2004; 27: 1427-1432
7. Lee DH, Jacobs DR Jr, Gross M, Kiefe CI, Roseman J, Lewis CE, Steffes M: Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem, 2003; 49: 1358-1366
8. André P, Balkau B, Born C, Charles MA, Eschwège E, DESIR study group: Three-year increase of gammaglutamyltransferase level and development of type 2 diabetes in middle-aged man and women: the DESIR cohort. Diabetologia, 2006; 49: 2599-2603
9. Rantala AO, Lilja M, Kauma H, Savolainen MJ, Reunanen A, Kesäniemi YA: Gamma-glutamyl transpeptidase and the metabolic syndrome. J Intern Med, 2000; 248: 230-238
10. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun, 1999; 257: 79-83
11. Goldstein BJ, Scalia R: Adiponectin: a novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab, 2004; 89: 2563-2568
12. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, Knowler WC, Krakoff J: Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet, 2002; 360: 57-58
13. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y: Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation, 1999; 100: 2473-2476
14. Kim JA, Kim SM, Yoon D: The relationship between gamma-glutamyltransferase and adiponectin in nonalcoholic women. Metabolism, 2007; 56: 578-582
15. Lee MY, Koh SB, Koh JH, Nam SM, Shin JY, Shin YG, Kong ID, Ryu SY, Lee TY, Park JK, Chung CH: Relationship between gamma-glutamyltransferase and metabolic syndrome in a Korean population. Diabet Med, 2008; 25: 469-475
16. Cohn JN: Vascular wall function as a risk marker for cardiovascular disease. J Hypertens, 1999; 17: S41-S44
17. Wilkinson IB, Webb DJ, Cockcroft JR: Aortic pulse-wave velocity. Lancet, 1999; 354: 1996-1997
18. van Popele NM, Grobbee DE, Bots ML, Asmar R, Topouchian J, Reneman RS, Hoeks AP, van der Kuip DA, Hofman A, Witteman JC: Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke, 2001; 32: 454-460
19. Yamashina A, Tomiyama H, Arai T, Hirose K, Koji Y, Hirayama Y, Yamamoto Y, Hori S: Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res, 2003; 26: 615-622
20. Imanishi R, Seto S, Toda G, Yoshida M, Ohtsuru A, Koide Y, Baba T, Yano K: High brachial-ankle pulse wave velocity is an independent predictor of the presence of coronary artery disease in men. Hypertens Res, 2004; 27: 71-78
21. Saijo Y, Utsugi M, Yoshioka E, Horikawa N, Sato T, Gong Y, Kishi R: The relationship of gamma-glutamyltransferase to C-reactive protein and arterial stiffness. Nutr Metab Cardiovasc Dis, 2008; 18: 211-219
22. Yoon SJ, Lee HS, Lee SW, Yun JE, Kim SY, Cho ER, Lee SJ, Jee EJ, Lee HY, Park J, Kim HS, Jee SH: The association between adiponectin and diabetes in the Korean population. Metabolism, 2008; 57: 853-857
23. Zeng Q, Sun XN, Fan L, Ye P: Correlation of body composition with cardiac function and arterial compliance. Clin Exp Pharmacol Physiol, 2008; 35: 78-82
24. Mason JE, Starke RD, Van Kirk JE: Gamma-glutamyl transferase: a novel cardiovascular risk biomarker. Prev Cardiol, 2010; 13: 36-41
25. Kawamoto R, Kohara K, Tabara Y, Miki T, Otsuka N: Serum gamma-glutamyl transferase levels are associated with metabolic syndrome in community-dwelling individuals. J Atheroscler Thromb, 2009; 16: 355-362
26. Kang YH, Min HK, Son SM, Kim IJ, Kim YK: The association of serum gamma glutamyltransferase with components of the metabolic syndrome in the Korean adults. Diabetes Res Clin Pract, 2007; 77: 306-313
27. Ikai E, Honda R, Yamada Y: Serum gamma-glutamyl transpeptidase level and blood pressure in nondrinkers: a possible pathogenetic role of fatty liver in obesity-related hypertension. J Hum Hypertens, 1994; 8: 95-100
28. Nilssen O, Førde OH: Seven-year longitudinal population study of change in gamma-glutamyltransferase: the Tromsø Study. Am J Epidemiol, 1994; 139: 787-792
29. Whitfield JB: Gamma glutamyl transferase. Crit Rev Clin Lab Sci, 2001; 38: 263-355
30. Lee DH, Blomhoff R, Jacobs DR Jr: Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res, 2004; 38: 535-539
31. Pompella A, Emdin M, Passino C, Paolicchi A: The significance of serum gamma-glutamyltransferase in cardiovascular diseases. Clin Chem Lab Med, 2004; 42: 1085-1091
32. Roberts CK, Barnard RJ, Sindhu RK, Jurczak M, Ehdaie A, Vaziri ND: Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in dietinduced metabolic syndrome. Metabolism, 2006; 55: 928-934
33. Stocker R, Keaney JF Jr: Role of oxidative modifications in atherosclerosis. Physiol Rev, 2004; 84: 1381-1478
34. Araki T, Emoto M, Yokoyama H, Maeno T, Hatsuda S, Mori K, Koyama H, Shoji T, Inaba M, Nishizawa Y: The association of plasma adiponectin level with carotid arterial stiffness. Metabolism, 2006; 55: 587-592
35. Higashiura K, Ura N, Ohata J, Togashi N, Takagi S, Saitoh S, Murakami H, Takagawa Y, Shimamoto K: Correlations of adiponectin level with insulin resistance and atherosclerosis in Japanese male populations. Clin Endocrinol, 2004; 61: 753-759
36. Ferreira I, Boreham CA, Twisk JW, Gallagher AM, Young IS, Murray LJ, Stehouwer CD: Clustering of metabolic syndrome risk factors and arterial stiffness in young adults: the Northern Ireland Young Hearts Project. J Hypertens, 2007; 25: 1009-1020
37. Kizu A, Koyama H, Tanaka S, Maeno T, Komatsu M, Fukumoto S, Emoto M, Shoji T, Inaba M, Shioi A, Miki T, Nishizawa Y: Arterial wall stiffness is associated with peripheral circulation in patients with type 2 diabetes. Atherosclerosis, 2003; 170: 87-91
38. Taniwaki H, Shoji T, Emoto M, Kawagishi T, Ishimura E, Inaba M, Okuno Y, Nishizawa Y: Femoral artery wall thickness and stiffness in evaluation of peripheral vascular disease in type 2 diabetes mellitus. Atherosclerosis, 2001; 158: 207-214
39. Stehouwer CD, Ferreira I: Diabetes, lipids and other risk factors. In: Arterial stiffness in hypertension. ed by Safar ME and O'Rourke MF, pp427-456, Elsevier, Inc, Amsterdam, Netherlands, 2006
40. Weber T, Auer J, O'Rourke MF, Kvas E, Lassnig E, Berent R, Eber B: Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation, 2004; 109: 184-189